Javascript must be enabled to continue!
Right-Dominant Fulminant Myocarditis Managed With Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) and Impella Support (EC-PELLA)
View through CrossRef
Fulminant myocarditis may present with rapidly progressive cardiogenic shock and biventricular failure. Although fulminant myocarditis often presents with global left ventricular (LV) failure, unusual right-ventricular-predominant forms can mimic inferior ST-elevation myocardial infarction (STEMI) and delay diagnosis. Mechanical circulatory support (MCS) is often required, and veno-arterial extracorporeal membrane oxygenation and Impella (EC-PELLA) has been used in select cases. However, guidance is limited regarding its role when recovery is uncertain. A previously well, 72 year old woman collapsed with complete heart block, inferior ST-elevation, and isolated right ventricular dysfunction—features that strongly suggested inferior STEMI, yet angiography was nonobstructive. Despite inotropes and mechanical ventilation, the patient deteriorated, prompting initiation of VA-ECMO. Progressive vasoplegia, end-organ failure, and pulmonary edema necessitated placement of an Impella CP device. Myocardial biopsy confirmed lymphocytic myocarditis. Despite maximal support; there was no LV recovery, and the patient developed multiorgan failure. After multidisciplinary review and family discussions, support was withdrawn. This case illustrates both the diagnostic pitfall of right-dominant fulminant myocarditis masquerading as STEMI and the escalating role of EC-PELLA when shock is refractory, while underscoring the challenge of determining futility in the absence of early recovery. We discuss hemodynamic goals, escalation strategy, and prognostic uncertainty, emphasizing the need for early collaborative decision-making frameworks.
Ovid Technologies (Wolters Kluwer Health)
Title: Right-Dominant Fulminant Myocarditis Managed With Veno-Arterial Extracorporeal Membrane Oxygenation (ECMO) and Impella Support (EC-PELLA)
Description:
Fulminant myocarditis may present with rapidly progressive cardiogenic shock and biventricular failure.
Although fulminant myocarditis often presents with global left ventricular (LV) failure, unusual right-ventricular-predominant forms can mimic inferior ST-elevation myocardial infarction (STEMI) and delay diagnosis.
Mechanical circulatory support (MCS) is often required, and veno-arterial extracorporeal membrane oxygenation and Impella (EC-PELLA) has been used in select cases.
However, guidance is limited regarding its role when recovery is uncertain.
A previously well, 72 year old woman collapsed with complete heart block, inferior ST-elevation, and isolated right ventricular dysfunction—features that strongly suggested inferior STEMI, yet angiography was nonobstructive.
Despite inotropes and mechanical ventilation, the patient deteriorated, prompting initiation of VA-ECMO.
Progressive vasoplegia, end-organ failure, and pulmonary edema necessitated placement of an Impella CP device.
Myocardial biopsy confirmed lymphocytic myocarditis.
Despite maximal support; there was no LV recovery, and the patient developed multiorgan failure.
After multidisciplinary review and family discussions, support was withdrawn.
This case illustrates both the diagnostic pitfall of right-dominant fulminant myocarditis masquerading as STEMI and the escalating role of EC-PELLA when shock is refractory, while underscoring the challenge of determining futility in the absence of early recovery.
We discuss hemodynamic goals, escalation strategy, and prognostic uncertainty, emphasizing the need for early collaborative decision-making frameworks.
Related Results
The journey of pediatric ECMO
The journey of pediatric ECMO
Introduction:
Extracorporeal membrane oxygenation (ECMO) is an adaptation of conventional cardiopulmonary bypass techniques used for long-term support of respir...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Incidence of Thrombocytopenia and Heparin Induced Thrombocytopenia in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO) Compared to Cardiopulmonary Bypass and the Limited Sensitivity of Pre-Test Probability Score
Incidence of Thrombocytopenia and Heparin Induced Thrombocytopenia in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO) Compared to Cardiopulmonary Bypass and the Limited Sensitivity of Pre-Test Probability Score
Abstract
Introduction
Extracorporeal membrane oxygenation (ECMO) is a life saving measure for severe respiratory (veno-venous ECMO [VV-ECMO]) or cardi...
Hemodynamic analysis of left ventricular unloading with Impella versus IABP during VA-ECMO
Hemodynamic analysis of left ventricular unloading with Impella versus IABP during VA-ECMO
Purpose
The utilization of intra-aortic balloon pump (IABP) and Impella has been suggested as means of left ventricular unloading in veno-arterial extracorporeal membrane oxyg...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
ECMO physiology
ECMO physiology
Temporary mechanical cardiopulmonary support may be used intraoperatively to facilitate cardiac surgery. Over the past decade, this intervention has been extended for prolonged use...
Appropriate timing of veno-arterial extracorporeal membrane oxygenation initiation after cardiac surgery
Appropriate timing of veno-arterial extracorporeal membrane oxygenation initiation after cardiac surgery
Abstract
Background
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) can be initiated during cardiac surgery or later in ICU according to...

